Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02399254 · ClinicalTrials.gov registry record
The Trajectory of Physical Activity Following Pulmonary Rehabilitation
A clinical trial of COPD and Pulmonary Disease, Chronic Obstructive, sponsored by Trinity Health Of New England.
- Completed
- Registry status
- 21
- Enrollment target
- 4
- Study locations
NCT02399254: Completed study of COPD and Pulmonary Disease, Chronic Obstructive, sponsored by Trinity Health Of New England.
NCT02399254 is a study of COPD and Pulmonary Disease, Chronic Obstructive that has completed, run by Trinity Health Of New England. The registered enrollment target is 21 participants, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02399254, a study of COPD and Pulmonary Disease, Chronic Obstructive, has completed, sponsored by Trinity Health Of New England.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
- 4
- Study locations
Study Summary
Pulmonary rehabilitation clearly increases exercise capacity, but its effect on physical activity in the home and community settings is less clear. It may take a longer time for this increase in physical activity to occur. It has been stated in an editorial that it takes 3 months to train the muscles but 6 months to train the brain. The Investigators will first evaluate the change in physical activity following pulmonary rehabilitation using state-of-the-science motion detectors, then Investigators will follow the trajectory of physical activity over the next several months.
Primary Outcome
Investigators will look at changes in directly-measured physical activity (minutes per day of walking activity from the DynaPort) between the 12 ± 3 week assessment and baseline.
Conditions Studied
Study Locations (4)
Connecticut
- Saint Francis Hospital and Medical Center - Hartford
- Gaylord Hospital - Wallingford
- VA Connecticut Research and Education Foundation - West Haven
Rhode Island
- Ocean State Research Institute - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-06-15 |
What the finished NCT02399254 record still lists
NCT02399254 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with COPD appearing as the primary indexed condition, and to 0 interventions.
NCT02399254 reports a single indexed study location in Connecticut, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT02399254 about?
NCT02399254 is a clinical study titled "The Trajectory of Physical Activity Following Pulmonary Rehabilitation". Pulmonary rehabilitation clearly increases exercise capacity, but its effect on physical activity in the home and community settings is less clear. It may take a longer time for this increase in physical activity to occur. It has been stated in an editorial that it takes 3 months to train the muscle...
What is the current status of trial NCT02399254?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2015-04. Estimated completion is 2017-06-15.
What conditions does trial NCT02399254 study?
This clinical trial studies the following conditions: COPD, Pulmonary Disease, Chronic Obstructive.
Who is sponsoring clinical trial NCT02399254?
This trial is sponsored by Trinity Health Of New England, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02399254 being conducted?
This trial has 4 study locations across Connecticut, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02399254's enrollment target sits among peer trials
21 74th of 85 higher than 12 of 85 other COPD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
Pulmonary Hypertension SOLAR
RECRUITING · Phase 2
-
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RECRUITING · Phase 1
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Relationship of Inflammation and Pulmonary Function to Fungal Translocation in HIV
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia